Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evidence of cytotoxicity in ulcerative colitis from immunofluorescent staining of the rectal mucosa.

× No keyword cloud information.

12 in total

1. C3 metabolism in ulcerative colitis and Crohn's disease.

Authors: H J Hodgson; B J Potter; D P Jewell
Journal: Clin Exp Immunol Date: 1977-06 Impact factor: 4.330

2. Polymorphonuclear leukocyte function in ulcerative colitis and Crohn's disease.

Authors: A P Kirk; J Cason; J N Fordham; K A Brown; D H Goddard; E J Holborow; J E Lennard-Jones
Journal: Dig Dis Sci Date: 1983-03 Impact factor: 3.199

3. Circulating immune complexes in Crohn's disease. Their characterization and interrelationship with components of the complement system.

Authors: E R Richens; C M Thorp; P W Bland; N D Hall
Journal: Dig Dis Sci Date: 1982-02 Impact factor: 3.199

4. Complement inhibitors and immunoconglutinins in ulcerative colitis and Crohn's disease.

Authors: B J Potter; D J Brown; A Watson; D P Jewell
Journal: Gut Date: 1980-12 Impact factor: 23.059

5. In vitro synthesis of immunoglobulins, secretory component, complement and lysozyme by human gastrointestinal tissues. II. Pathological tissues.

Authors: D B McClelland; D J Shearman; R F Lai A Fat; R van Furth
Journal: Clin Exp Immunol Date: 1976-01 Impact factor: 4.330

6. Deposits of terminal complement complex (TCC) in muscularis mucosae and submucosal vessels in ulcerative colitis and Crohn's disease of the colon.

Authors: T S Halstensen; T E Mollnes; O Fausa; P Brandtzaeg
Journal: Gut Date: 1989-03 Impact factor: 23.059

Evidence of cytotoxicity in ulcerative colitis from immunofluorescent staining of the rectal mucosa.

1. C3 metabolism in ulcerative colitis and Crohn's disease.

2. Polymorphonuclear leukocyte function in ulcerative colitis and Crohn's disease.

3. Circulating immune complexes in Crohn's disease. Their characterization and interrelationship with components of the complement system.

4. Complement inhibitors and immunoconglutinins in ulcerative colitis and Crohn's disease.

5. In vitro synthesis of immunoglobulins, secretory component, complement and lysozyme by human gastrointestinal tissues. II. Pathological tissues.

6. Deposits of terminal complement complex (TCC) in muscularis mucosae and submucosal vessels in ulcerative colitis and Crohn's disease of the colon.

7. Rectal mucosal plasma cells in inflammatory bowel disease.

8. Local complement activation in inflammatory bowel disease.

9. Local immunity in ulcerative colitis: evidence for defective secretory IgA production.

10. Population changes in immunoglobulin-containing mononuclear cells in dextran sulfate sodium-induced coltitis.